Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Akanksha Bakshi

Read How Analysts Reacted To Cintas's Q3 Results

  • Cintas Corp's (NASDAQ:CTASprice target was raised to $493 from $460 by Goldman Sachs analyst George Tong while maintaining the Buy rating on the shares.
  • Tong predicts continued strength from the healthcare sector that is increasingly adopting uniform rental programs at Cintas post-COVID due to cost and hygiene benefits.
  • RelatedCintas' Q3 Results Beat Estimates, Clocks 10% Revenue Growth
  • The analyst notes the company is well-positioned to handle higher input costs with pricing power and technology-enabled efficiencies.
  • Morgan Stanley lowered its price target on CTAS to $389 (a downside of 2.8%) from $416 while maintaining an Equal-Weight rating on the shares.
  • Price Action: CTAS shares are trading lower by 0.26% at $400.31 on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.